Abstract Background: In Canada, public drug plans may restrict the use of newer topical
antiglaucoma agents. The goals of this retrospective study were to estimate the proportion of …

Purpose: To investigate whether a self-reported history of allergy to sulfa-based drugs is a
predictor for subsequent adverse reactions to topical carbonic anhydrase inhibitors (CAIs) …

With increasing longevity, patients are developing more and more chronic diseases that
require treatment with medications. Yet, it is not fully understood the extent by which these …

PURPOSE: To determine the association between systemic antihypertensive medication
and incident open-angle glaucoma. DESIGN: Prospective population-based cohort study …

Glaucoma is the most common cause of blindness, which significantly reduces quality of life.
Most glaucoma cases are primary glaucoma; nevertheless, many patients suffer from …

Alan L. Robin, MD Page 1 The role of o-agonists in glaucoma therapy Alan L. Robin, MD o-Agonists
are a relatively old class of medications, the topical use of which lowers eye pressure. Clonidine …

As with many diseases, glaucoma increases in frequency in older populations, and is very
often encountered in patients taking multiple medications. While the exact mechanism of …

Purpose We investigated the mechanism of drug-induced transient myopia, anterior
chamber shallowing, and secondary angle-closure glaucoma in a young woman. Method …

Numerous pharmacological agents, including the sulfonamides, have been reported to
cause acute transient myopia. 1 Rarely, such episodes can be associated with the …

A 71-year-old woman with depression had been treated with an antidepressant (maprotiline)
and antianxiety agents (clotiazepam and alprazolam). She had previously complained of …